Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) EBT (2016 - 2026)

MedWellAI has reported EBT over the past 11 years, most recently at -$287617.0 for Q4 2025.

  • Quarterly EBT rose 12.34% to -$287617.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.8 million through Dec 2025, down 163.1% year-over-year, with the annual reading at -$2.9 million for FY2025, 67.78% up from the prior year.
  • EBT was -$287617.0 for Q4 2025 at MedWellAI, up from -$580888.0 in the prior quarter.
  • Over five years, EBT peaked at $1.3 million in Q3 2021 and troughed at -$22.1 million in Q2 2023.
  • The 5-year median for EBT is -$608071.0 (2025), against an average of -$3.0 million.
  • The largest YoY upside for EBT was 446.59% in 2021 against a maximum downside of 3630.14% in 2021.
  • A 5-year view of EBT shows it stood at -$515261.0 in 2021, then crashed by 48.2% to -$763597.0 in 2022, then soared by 52.91% to -$359563.0 in 2023, then increased by 8.75% to -$328094.0 in 2024, then rose by 12.34% to -$287617.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's EBT are -$287617.0 (Q4 2025), -$580888.0 (Q3 2025), and -$341537.0 (Q2 2025).